Gait and Motion Analysis Laboratory, MossRehab, Elkins Park, PA, 19027, USA.
Penn State University, 1600 Woodland Road, Abington, PA, 19001, USA.
J Neuroeng Rehabil. 2023 Oct 4;20(1):134. doi: 10.1186/s12984-023-01243-3.
Practicality of implementation and dosing of supplemental gait training in an acute stroke inpatient rehabilitation setting are not well studied but can have positive impact on outcomes.
To determine the feasibility of early, intense supplemental gait training in inpatient stroke rehabilitation, compare functional outcomes and the specific mode of delivery.
Assessor blinded, randomized controlled trial in a tertiary Inpatient Rehabilitation Facility.
Thirty acute post-stroke patients with unilateral hemiparesis (≥ 18 years of age with a lower limb MAS ≤ 3).
Lokomat® or conventional gait training (CGT) in addition to standard mandated therapy time.
Number of therapy sessions; adverse events; functional independence measure (FIM motor); functional ambulation category (FAC); passive range of motion (PROM); modified Ashworth scale (MAS); 5 times sit-to-stand (5x-STS); 10-m walk test (10MWT); 2-min walk test (2MWT) were assessed before (pre) and after training (post).
The desired supplemental therapy was implemented during normal care delivery hours and the patients generally tolerated the sessions well. Both groups improved markedly on several measures; the CGT group obtained nearly 45% more supplemental sessions (12.8) than the Lokomat® group (8.9). Both groups showed greater FIM improvement scores (discharge - admission) than those from a reference group receiving no supplemental therapy. An overarching statistical comparison between methods was skewed towards a differential benefit (but not significant) in the Lokomat® group with medium effect sizes. By observation, the robotic group completed a greater number of steps, on average. These results provide some evidence for Lokomat® being a more efficient tool for gait retraining by providing a more optimal therapy "dose".
With careful planning, supplemental therapy was possible with minimal intrusion to schedules and was well tolerated. Participants showed meaningful functional improvement with relatively little supplemental therapy over a relatively short time in study.
在急性脑卒中住院康复环境中,补充步态训练的实施和剂量的实用性尚未得到充分研究,但可能对结果产生积极影响。
确定在住院脑卒中康复中早期强化补充步态训练的可行性,比较功能结局和具体的交付方式。
在三级住院康复机构进行评估员盲法、随机对照试验。
30 名单侧偏瘫急性脑卒中患者(年龄≥18 岁,下肢 MAS≤3)。
在标准规定的治疗时间之外使用 Lokomat®或常规步态训练(CGT)。
治疗次数;不良事件;功能独立性测量(FIM 运动);功能性步行分类(FAC);被动关节活动度(PROM);改良 Ashworth 量表(MAS);5 次坐立试验(5x-STS);10 米步行试验(10MWT);2 分钟步行试验(2MWT)在训练前(pre)和训练后(post)进行评估。
所需的补充治疗是在正常护理时间内实施的,患者通常能很好地耐受治疗。两组在多项指标上均有显著改善;CGT 组比 Lokomat®组(8.9)多接受了近 45%的补充治疗(12.8)。两组的 FIM 改善评分(出院-入院)均高于未接受补充治疗的参考组。对方法进行的总体统计比较偏向于 Lokomat®组的差异受益(但无统计学意义),具有中等效应大小。通过观察,机器人组平均完成了更多的步数。这些结果为 Lokomat®通过提供更优化的治疗“剂量”成为更有效的步态再训练工具提供了一些证据。
通过精心规划,补充治疗在不干扰日程的情况下是可行的,且患者耐受性良好。参与者在研究期间接受相对较少的补充治疗后,在相对较短的时间内表现出了有意义的功能改善。